195 related articles for article (PubMed ID: 23800539)
1. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
Murungi LM; Kamuyu G; Lowe B; Bejon P; Theisen M; Kinyanjui SM; Marsh K; Osier FH
Vaccine; 2013 Aug; 31(37):3936-42. PubMed ID: 23800539
[TBL] [Abstract][Full Text] [Related]
2. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.
Kangoye DT; Mensah VA; Murungi LM; Nkumama I; Nebie I; Marsh K; Cisse B; Bejon P; Osier FH; Sirima SB;
Vaccine; 2016 Jan; 34(1):160-6. PubMed ID: 26541134
[TBL] [Abstract][Full Text] [Related]
4. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
Fowkes FJ; Richards JS; Simpson JA; Beeson JG
PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
[TBL] [Abstract][Full Text] [Related]
5. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
[TBL] [Abstract][Full Text] [Related]
8. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
[TBL] [Abstract][Full Text] [Related]
9. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
Agak GW; Bejon P; Fegan G; Gicheru N; Villard V; Kajava AV; Marsh K; Corradin G
Vaccine; 2008 Apr; 26(16):1963-71. PubMed ID: 18342997
[TBL] [Abstract][Full Text] [Related]
11. Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
Olotu A; Fegan G; Wambua J; Nyangweso G; Ogada E; Drakeley C; Marsh K; Bejon P
PLoS One; 2012; 7(3):e32929. PubMed ID: 22479349
[TBL] [Abstract][Full Text] [Related]
12. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
[TBL] [Abstract][Full Text] [Related]
14. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
[TBL] [Abstract][Full Text] [Related]
15. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
[TBL] [Abstract][Full Text] [Related]
16. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.
Mugyenyi CK; Elliott SR; McCallum FJ; Anders RF; Marsh K; Beeson JG
PLoS One; 2013; 8(7):e68304. PubMed ID: 23861883
[TBL] [Abstract][Full Text] [Related]
18. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
Osier FH; Feng G; Boyle MJ; Langer C; Zhou J; Richards JS; McCallum FJ; Reiling L; Jaworowski A; Anders RF; Marsh K; Beeson JG
BMC Med; 2014 Jul; 12():108. PubMed ID: 24980799
[TBL] [Abstract][Full Text] [Related]
19. Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
Akpogheneta OJ; Dunyo S; Pinder M; Conway DJ
Parasite Immunol; 2010 Apr; 32(4):296-304. PubMed ID: 20398230
[TBL] [Abstract][Full Text] [Related]
20. Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.
Murungi LM; Sondén K; Llewellyn D; Rono J; Guleid F; Williams AR; Ogada E; Thairu A; Färnert A; Marsh K; Draper SJ; Osier FHA
Infect Immun; 2016 Apr; 84(4):950-963. PubMed ID: 26787721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
